✦ LIBER ✦

Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry

✍ Scribed by Richard E. Caves, Michael D. Whinston, Mark A. Hurwitz, Ariel Pakes and Peter Temin

Book ID: 125768412
Publisher: Brookings Institution
Year: 1991
Weight: 1006 KB
Volume: 1991
Category: Article
ISSN: 1057-8641
DOI: 10.2307/2534790

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Post-patent barriers to entry in the pha

Post-patent barriers to entry in the pharmaceutical industry

✍ F.M. Scherer 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Strategic Entry Deterrence and the Behav

Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration

✍ Ellison, Glenn; Ellison, Sara Fisher 📂 Article 📅 2011 🏛 American Economic Association 🌐 English ⚖ 752 KB

The Dual Effects of Intellectual Propert

The Dual Effects of Intellectual Property Regulations: Within‐ and Between‐Patent Competition in the U.S. Pharmaceuticals Industry*

✍ Lichtenberg, Frank R.; Philipson, Tomas J. 📂 Article 📅 2002 🏛 University of Chicago Press 🌐 English ⚖ 250 KB

The effect of Paragraph IV decisions and

The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms

✍ Laura E. Panattoni 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 352 KB

Product innovation, product–market compe

Product innovation, product–market competition and persistent profitability in the U.S. pharmaceutical industry

✍ Peter W. Roberts 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Increasingly, strategy scholars are exploring the relationships between innovation, competition, and the persistence of superior profits. Sustained high profitability may result when a firm repeatedly introduces valuable innovations that service previously unmet consumer demands. While the returns t

Competition in the U.S. banking industry

✍ Sherrill Shaffer 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 225 KB